← Back to Forbion profile
Forbion related stories
All articles and analysis
peHUB Wire: Tuesday, November 10, 2009Tuesday Talkback
- peHUB Wire: Tuesday, November 10, 2009
Tuesday Talkback
- Exit watch, week of Oct. 12, 2009
Briefs about acquisitions of VC-backed companies Increo, The FeedRoom and others from the past week
- VCs sells Fovea
Sanofi buys French biotech
- peHUB Wire: Thursday, October 1, 2009
Q3 Data Dump
- peHUB Wire: Thursday, October 1, 2009
Q3 Data Dump
- arGEN-X Raises €9.5 Million
arGEN-X, a Dutch drug company focused on antidoby discovery and development, has raised €9.5 million in Series A funding. Forbion Capital Partners and LSP co-led the round, and were joined by KBC Private Equity, BioGeneration Ventures and seed backers Erasmus MC Biomedical Fund and Thuja Capital Healthcare Funds.
- Forbion co-leads €9.5m financing
Syndicate invests in life science